David Barbie
, Associate Director · Mass General Brigham
Credentials: · · · ·
History
- Present
Lowe Center for Thoracic Oncology · Mass General Brigham
- Present
- 2005–2007
- 1998–2002
- 1994–1998
Harvard College
Research
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
Nature · 2009 · First of 35 authors · 3,074 citations
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
Cell · 2018 · 1,576 citations
Mechanisms of resistance to immune checkpoint inhibitors
Review · British Journal of Cancer · 2018 · 1,142 citations
26 papers
23 papers · 2 as a fellow
20 papers
16 papers · 13 as a fellow
- EK
15 papers · 11 as a fellow
15 papers
- MA
14 papers
13 papers
Grants
- 2026–2031
Unleashing IFN Signal Transduction to Prime HNSCC Immunogenicity
National Cancer Institute · R01
PI · $742.4K · Broad Institute, Inc.
- 2015–2031
Targeting the Cytokine Circuitry of KRAS Driven Lung Cancer
National Cancer Institute · R01
Contact PI · $4.5M · Dana-Farber Cancer Inst
- 2022–2027
Dana Farber/Harvard Cancer Center SPORE in Lung Cancer
National Cancer Institute · P50
Contact PI · $11.4M · Dana-Farber Cancer Inst
- 1997–2026
Dana-Farber/Harvard Cancer Center
National Cancer Institute · P30
Project lead · $95.2K · Dana-Farber Cancer Inst